Uric acid and evaluate the coronary vascular stenosis Gensini score correlation research and in gender differences

Author:

Yang Bao1,Ma Kanghua1,Xiang Rui1,Yang Guoli1,Luo Yue1,Wu Fan1,Mao Min1

Affiliation:

1. The First Affiliated Hospital of Chongqing Medical University

Abstract

Abstract Background and aims: Recent studies have shown that the negative effects of uric acid (UA) on coronary arteries determine the severity of atherosclerotic disease and may serve as a non-invasive biomarker for assessing the degree of coronary artery stenosis. The aim of this study was to investigate the association between serum uric acid levels and the Gensini score, which reflects the severity of coronary artery disease. Methods:860 individuals with suspected coronary heart disease, who had undergone coronary angiography, were selected as the participants for this study. Based on the findings of the angiography, they were categorized into two groups: the coronary heart disease (CHD) group (n=625) and the control group (n=235). The uric acid levels and other clinical data were compared between these groups. Additionally, the prevalence of coronary heart disease and Gensini score were compared between the groups, considering gender-specific quartiles of uric acid levels. The clinical baseline data were analyzed using appropriate statistical methods, and multivariate logistic regression analysis was conducted to identify independent risk factors for coronary heart disease. Results: Of 860 patients (mean age, 63.97±11.87 years), 528 were men (mean age, 62.06±11.5 years) and 332 were women (mean age, 66.99±10.11 years). The proportion of smoking, diabetes, hypertension, and hyperlipidemia in the coronary heart disease group was higher than that in the control group (P<0.05). HbA1C, Gensini score, BMI, TG and hsCRP in the coronary heart disease group were higher than those in the control group (P <0.05), and HDL-C was lower than that in the control group (P<0.05). There were no significant differences in age, heart rate, Cr, TC, LDL-C and ca2+ between the two groups (P> 0.05).Multivariate logistic regression analysis showed that age, hypertension, hsCRP and SUA levels increased the risk of coronary heart disease, and the difference was statistically significant(OR=1.034,95%CI 1.016-1.052, P=0.001; OR=1.469,95%CI 1.007-2.142, P=0.046;OR=1.064,95%CI 1.026-1.105, P=0.001; OR=1.011,95%CI 1.008-1.014, P<0.001). Conclusion: Uric acid exhibits a positive correlation with the Gensini score, serving as a standalone influential determinant for evaluating the extent of coronary artery stenosis and possessing a foretelling impact on the severity of coronary artery disease.

Publisher

Research Square Platform LLC

Reference31 articles.

1. Current Insights into Exercise-based Cardiac Rehabilitation in Patients with Coronary Heart Disease and Chronic Heart Failure [J];NICHOLS S;Int J Sports Med,2021

2. [Impact of type 2 diabetes mellitus on the progression and revascularization of coronary non-target lesions in patients with coronary heart disease] [J];WANG J;Zhonghua xin xue guan bing za zhi,2020

3. Department of Error [J]. Lancet. 2020;396(10262):1562. http://doi.org/10.1016/s0140-6736(20)32226-1.

4. BENJAMIN E J MOZAFFARIAND, GO A S, et al. Circulation. 2016;133(4):e38–360. http://doi.org/10.1161/cir.0000000000000350. Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association [J].

5. VIRANI SS, ALONSO A, BENJAMIN E J, et al. Circulation. 2020;141(9):e139–e596. http://doi.org/10.1161/cir.0000000000000757. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association [J].

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3